YOUNG DAVID (Chief Executive Officer) purchased 153.9% of their position (124.50K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $99.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/29/2025ACC: 0000897069-25-000132
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+124.50K
Net shares
Net buyer
$99.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
124.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+124.50K
Price / share
$0.80
Trade value
$99.29K
% of position
153.9%
1/27/2025
80.91K→205.41K
Total
Net shares
+124.50K
Net value
$99.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2025 | P · Purchase | +124.50K | $0.80 | $99.29K | 153.9% | 80.91K | 205.41K |
| Total | +124.50K | $99.29K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned18.54K
Common Stock
IndirectShares owned30.98K
Common Stock
IndirectShares owned10.79K
Total
60.31K indirect60.31K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.54K | Indirect |
| Common Stock | 30.98K | Indirect |
| Common Stock | 10.79K | Indirect |
| Total | 60.31K | 60.31K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported